Pfizer/BioNTech Vaccine
Neutralising antibodies can be marker of COVID-19 vaccine efficacy

A new research shows that even a small quantity of the neutralising antibodies indicates a strong efficacy of the vaccine

Explained: How Intellectual Property Rights are blocking vaccine production

What is standing in the way of expanding production and carrying out mass vaccination campaigns across the world?

Lack of political will and IPR rules stand in the way of mass vaccination for COVID-19

A proposal made by India and South Africa in October last year to waive certain Intellectual Property Rights (IPR) of COVID vaccines has gained massive support across the world. Despite its potential to prevent millions of avoidable deaths, the US and its allies continue to block the proposal at the WTO.

Why Big Pharma shouldn’t have any control over COVID-19 vaccines

While a public desperate for protection against COVID-19 is quick to shame “vaccine hunters,” the real culprits are the companies refusing to share their publicly funded intellectual property and the governments allowing them to get away with it.

COVID-19 vaccines: How soon will life become normal?

Dr. Satyajit Rath talks about the progress of different vaccination campaigns and how the vaccines are faring against the different COVID variants.

Vaccination in Belgium Belgian Workers Party slams Pfizer’s profit motive in COVID-19 vaccine sale

Pfizer Inc. is accused of aiming for more profits by not ensuring the delivery of the promised quantity of COVID-19 vaccines after it was found that medics could draw six doses of vaccine per bottle instead of the expected five doses

    × To Subscribe